What are you looking for? Write the name, title or any keyword related to what you are looking for and select which content category it belongs to. Search Fulltext search Activities Professionals Research groups News - Any - News ACE Foundation celebrates 15 years awarding Dr. Chester A. Mathis ACE Foundation, Catalan Institute of Applied Neuroscience, directed by Lluís Tàrraga and Mercè Boada, also leader of the Alzheimer group at Vall d'Hebron Institute of Research (VHIR), celebrated its 15th anniversary with a ceremony in the Auditorium of Barcelona. Dr. Chester A. Mathis, Professor of News Monitoring the PIA should be systematic in the critical Compartment syndrome is defined as an increase in pressure on any closed cavity and causes serious damage. In the case of the abdomen, causes respiratory distress and renal hemodynamics in the patient. The syndrome occurs when intra-abdominal pressure (IAP) increases above 15 mmHg. The elevation of News An apple for Multiple Sclerosis The leader of the Clinical Neuroimmunology group at Vall d'Hebron Institute of Research (VHIR) and director of the Centre for Multiple Sclerosis of Catalonia (CEM-Cat), along with the president of the Multiple Sclerosis Foundation (FEM), Rosamaria Estrany, presented the charity campaign 'An apple fo News UCTS and neuromuscular and mitochondria pathology laboratory appear in 'Redes' The Scientific-Technical Unit Support (UCTS) and the neuromuscular and mitochondria pathology laboratory, led by Dr. Antoni Andreu, of Vall d'Hebron Research Institute (VHIR) serve to illustrate the 86th edition of the TVE show 'Redes', 'Instead of disease, health care'. Eduard Punset interviews thi News VHIR's research facilitates the customization of therapy for hepatitis B and C Vall d'Hebron Research Institute (VHIR) participates in a study that aims to solve the current limitations that impede customizing anti-HBV and anti- HCV (hepatitis B and C) therapies. The project involves the application of ultra pyrosequencing and bioinformatic analysis, along with other technolog News A new treatment improves survival of patients with metastasic breast cancer A clinical research study, led by Dr. Javier Cortes, head of Program BREAST CANCER from Vall d'Hebron University Hospital and VHIO, has shown that eribulin (chemotherapy drug- Halichondria okadai, animal marine sponge) improves the prognosis of patients suffering from metastatic breast cancer. The s News Study reveals that it is crucial that critical care nurses are aware of the guidelines for the prevention of ventilator-associated pneumonia A study published recently in ‘Medicina Intensiva’, coordinated by the CIBER of Respiratory Diseases and Vall d'Hebron University Hospital, signifies the great importance of knowledge of guidelines for the prevention of ventilator-associated pneumonia (VAP) by intensive care nurses. Pneumonia is rec News VHIR leads project grants for health research from Instituto de Salud Carlos III Vall d'Hebron Institute of Research (VHIR) is the center associated with Spanish hospitals which received more grants from the Instituto de Salud Carlos III (ISCIII ) for the fourth quarter of 2010. The 31 projects, totaling the amount financed of 3,919,909.50 euros, from 23 different research group News European Rare Disease Day Dr. Antoni Andreu, Head of the Neuromuscular and Mitochondrial Diseases Research Group at Vall d’Hebron Research Institute (VHIR), is interviewed by OrphaNews on the occasion of European rare diseases day. Dr. Andreu, CIBERER member, explains his experience with McArdle disease database, a project t News VHIR's study proves the benefits of a not approved drug for the treatment of ADHD in adults A review study led by Vall d'Hebron Institute of Research (VHIR) has confirmed the efficacy of methylphenidate for adults with Attention Deficit Disorder with Hyperactivity (ADHD). So far, the European Union authorizes treatment with methylphenidate (a stimulant) for children with Attention Deficit News Vall d'Hebron organizes 'Ventilung', the first basic course in mechanical ventilation Ventilung, a course on basics of artificial ventilation and its main clinical applications, will be held at Vall d’Hebron University Hospital (HUVH) from 24 to 26 February, is co-organized by three groups of CIBER of Respiratory Diseases (CIBERES)-belonging to the Instituto de Salud Carlos III- led News Dr. Boada explains the keys of Alzheimer on TVE show 'Saber Vivir' Dr. Mercè Boada, Alzheimer's group leader at Vall d'Hebron Institute of Research (VHIR) appeared on Friday 18 February as the main guest of TVE morning show 'Saber Vivir', where she explained the keys to Alzheimer's and how it affects the daily lives of those affected, and the problems involved and News ISCIII's Master students visit VHIR Students of Master in Management R & D & I in Health Sciences from Institute of Health Carlos III (ISCIII) visited on February 18 the facilities of Vall d'Hebron Institute of Research (VHIR) to know the inner workings of each of its key areas. During the meeting, the leaders of the various units, in News VHIR works with Korean institutions in biomedical research Dr. Antoni Andreu, head of the group of neuromuscular and mitochondrial pathology, and Dr. Joan Montaner, head of neurovascular disease group of Vall d'Hebron Institute of Research (VHIR) participate from 17 to 19 February in Daegu (South Korea) in the second meeting of International Medical Researc News Dr. Reventós explains prostate cancer on Teletaxi with Justo Molinero The head of the Biomedical Research and Translational and Pediatric Oncology Unit at Vall d'Hebron, Institut de Recerca (VHIR), Dr. Jaume Reventós, explains his team's research on prostate cancer and other topics related to innovation and day-to-day research in-depth interview in the program 'Qui és News Inveready takes a stake in Transbiomed, the first spin-off of VHIR Inveready Seed Capital, Venture Capital led and participated by Inveready Group, has announced its investment in the company Transbiomed in its first round of funding. Inveready has taken a minority but significant in this firm, the first spin-off of Vall d'Hebron Research Institute (VHIR) in Barcel News Dr. Galiñanes participates in the special about heart attacks in '36, 5' show at BTV The head of Cardiac Surgery at the Heart Area of the University Hospital Vall d'Hebron, and head of the reparative therapy of heart group at Vall d'Hebron Institut de Recerca (VHIR), Dr. Manuel Galiñanes, explains that exercise is the key to living in health, even for people who suffer heart disease News 2nd SMD Integrated Diagnostic Workshop Units of Cytology, Immunophenotype and cytogenetics of Hematology from Hospital Vall d'Hebron organized on February 9 the second Integrated Diagnostics Workshop Myelodysplastic Syndromes (MDS) of clinical cases. The workshop second edition, led by Teresa Vallespí, hematologist of Vall d'Hebron Resea News TVE ‘Informe Semanal' highlights Vall d'Hebron as one of the pioneers in the new lines of cancer research TVE show 'Informe Semanal' covered on February 5, in the context of the ‘Day against cancer’, the new pioneering research lines that are carrying out some Spanish hospitals, including especially Vall d'Hebron. Dr. Josep Baselga, VHIO director, and Dr. Anna Vivancos, among others researchers, give th News EU communication action on VHIR’s Meta Hit project "http://www.youtube.com/user/ComedScienceFilms#p/u/8/pGpBj5T0-DY" COMED is a ‘Communication and Support Action’ within the Seventh Framework of the European Commission to communicate the results and activities of cutting-edge EU-funded health-research projects to the general public. One of them is t Pagination First page « Previous page ‹ … Page 161 Page 162 Current page 163 Page 164 Page 165 … Next page › Last page »
